Locations:
Search IconSearch

News & Insight

Social worker with patient
September 9, 2025/Cancer/News & Insight

Oncology Social Work a Lifeline in Blood Cancer Treatment

Lifetime Achievement award-winner reflects on psychosocial support and caregiver readiness

Dr. Mustafa Ali & patient
September 4, 2025/Cancer/News & Insight

Comparison of First-Line Chemotherapy for Adults with Acute Lymphoblastic Leukemia

Questions remain about the merits of asparaginase-based therapy

monoclonal antibody illustration
August 22, 2025/Cancer/News & Insight

New Essential Thrombocythemia Treatment Appears to Address Underlying Disease

Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Physician comforting patient
August 12, 2025/Cancer/News & Insight

Resilience Matters: Mental Wellness Tied to Higher Immunotherapy Success in Advanced Non-Small Cell Lung Cancer

Cleveland Clinic psychiatrist urges integrating psychosocial care into oncology

Dr. Tendulkar
July 21, 2025/Cancer/News & Insight

Radiation Therapy Effective for Treating Benign Proliferative Disease of the Extremities

Noninvasive treatment may slow progression of Dupuytren's disease and plantar fibromatrosis

Older patients
July 17, 2025/Cancer/News & Insight

CAR T-Cell Therapy Safe & Effective for Octogenarians with B-Cell Lymphoma

Age alone should not rule out patients from potentially curative treatment

Surgeon
June 30, 2025/Cancer/News & Insight

Potential for Deintensification of Surgical Interventions in Low-Risk Breast Cancer

Reconsidering axillary lymph node dissection as well as depth of surgical margins

Dendritic cell
June 26, 2025/Cancer/News & Insight

Avelumab Induces Natural Killer Cell Activation and Dendritic Cell Crosstalk

Researchers uncover profound differences in the mechanism of action between different PD-L1 checkpoint inhibitors

BackPage 1 of 13Next

Advertisement

Ad